C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 7/01 (2006.01) A61K 35/76 (2006.01) A61K 39/39 (2006.01) C07K 14/145 (2006.01) C12N 9/02 (2006.01) C12N 15/00 (2006.01)
Patent
CA 2673593
The present invention is directed to recombinant vaccines, based on a phage vector system, which enhance immunological response and allow rapid construction and deployment of vaccines.
L'invention concerne des vaccins recombinés reposant sur un système de vecteur phagique, qui renforcent la réponse immunologique et autorisent la construction et le déploiement rapide de vaccins.
Biswajit Biswas
Mckinstry Michael
Merril Carl R.
Biswajit Biswas
Hygea Biopharma Inc.
Mbm Intellectual Property Law Llp
Mckinstry Michael
Merril Carl R.
LandOfFree
Immunologically enhanced recombinant vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunologically enhanced recombinant vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunologically enhanced recombinant vaccines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1599249